The top 5 most-read chronic obstructive pulmonary disease (COPD) articles of 2024 covered topics such as inhaled medication risks, gabapentinoid use, and the link between high white blood cell ...

Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms. The Health and Well-being of an ACO Population. Time to Fecal Immunochemical Test Completion for Colorectal Cancer.

Inhaled Combination Therapy for COPD: A Once-a-Day Alternative? Jennifer Garcia. August 20, 2012. August 20, 2012 — A combination of fluticasone furoate and vilanterol (FF/VI) inhaled once daily ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...

Please provide your email address to receive an email when new articles are posted on . Outcomes may vary among different fixed-dose combination inhalers for COPD. Fewer severe acute exacerbations ...

Breo Ellipta dry powder inhaler is available in a 100mcg/25mcg strength. The product will be available during the third quarter of 2013. For more information call (888) 825-5249 or visit www.gsk.com .

To estimate the long-term benefits of combination LABAs and inhaled corticosteroids compared with LABAs alone, the investigators conducted a population-based, longitudinal cohort study from 2003 ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD).It contains an inhaled corticosteroid called ...

Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists (LABAs) and inhaled corticosteroid combination ...

The other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a.

β-agonist and anticholinergic agents reduce symptoms in patients with chronic obstructive pulmonary disease (COPD). In this randomized, placebo-controlled, crossover study, European researchers ...

Feb. 10 -- MONDAY, Feb. 9 (HealthDay News) -- The use of inhalers containing corticosteroids to treat chronic obstructive pulmonary disease (COPD) might increase the risk of pneumonia by as much ...